Institutions / Acuta Capital Partners, LLC
Acuta Capital Partners, LLC
CIK 1582844 · Institution · as of Dec 31, 2025
Portfolio value
$147.29M
Positions
30
As of
Dec 31, 2025
Top holdings
Dec 31, 2025View all 30 →
| Company | Value | % of portfolio |
|---|---|---|
| Terns Pharmaceuticals, Inc. | $25.74M | 17.5% |
| Praxis Precision Medicines, Inc. | $24.47M | 16.6% |
| Cidara Therapeutics Inc | $19.69M | 13.4% |
| Ocular Therapeutix, Inc | $12.78M | 8.7% |
| Whitehawk Therapeutics, Inc.WHWK | $8.25M | 5.6% |
| Bright Minds Biosciences Inc. | $6.59M | 4.5% |
| Compass Therapeutics, Inc. | $5.87M | 4.0% |
| Jazz Pharmaceuticals PLC | $4.93M | 3.3% |
| Insmed Inc | $4.50M | 3.1% |
| Argen SE - Adr | $4.08M | 2.8% |
| Surrozen, Inc./DESRZN | $4.03M | 2.7% |
| Amylyx Pharmaceuticals, Inc. | $4.03M | 2.7% |
| Minerva Neurosciences, Inc. | $2.85M | 1.9% |
| Tango Therapeutics, Inc. | $2.51M | 1.7% |
| Taysha Gene Therapies, Inc.TSHA | $2.50M | 1.7% |
| Zymeworks Inc. | $2.11M | 1.4% |
| Oculis Holding AG | $2.03M | 1.4% |
| Design Therapeutics, Inc.DSGN | $1.42M | 1.0% |
| Inhibrx Biosciences, Inc. | $1.29M | 0.9% |
| United Therapeutics Corp | $1.12M | 0.8% |
| Verastem, Inc. | $1.11M | 0.8% |
| Maze Therapeutics, Inc. | $828.6K | 0.6% |
| MoonLake ImmunotherapeuticsMLTX | $781.3K | 0.5% |
| Sutro Biopharma, Inc. | $780.4K | 0.5% |
| Dianthus Therapeutics, Inc. | $688.5K | 0.5% |
Activity
Dec 31, 2025
InsidersInstitutions
This fund's 13F position changes — what it's buying and selling.No quarter-over-quarter changes yet — position changes appear once we've ingested two consecutive 13F filings for this manager. We currently hold 1 quarter of holdings.